Aspirin, P2Y12 blockers, cilostazol, PAR-1 blockers and emerging antiplatelet therapies: can biomarkers guide clinical development and practice?
Beyond platelet functional testing: value in the aggregate
Clinical value of antiplatelet therapy in patients with acute coronary syndromes and in percutaneous coronary intervention
Functional testing methods for the antiplatelet effects of aspirin
Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists
Ticagrelor: from concept to clinical evaluation
Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy
Innovative biomarker development for personalized medicine in breast cancer care
MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
High-sensitivity assay detects biomarker associated with cardiac mortality
Transcription factor could be responsible for mammary oncogenesis
Novel biomarker identification method may enhance early detection of breast cancer
Seizure-generating region of epileptic brain could provide clues to help identify aberrant brain function
High levels of high-density lipoprotein cholesterol may be associated with decreased risk of Alzheimer's disease
Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer
Applied strategies towards EEG/MEG biomarker identification in clinical and cognitive research
Acknowledgements